Traders Buy Large Volume of NRx Pharmaceuticals Call Options (NASDAQ:NRXP)

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) saw unusually large options trading on Thursday. Traders bought 7,048 call options on the company. This is an increase of approximately 79% compared to the typical daily volume of 3,928 call options.

Shares of NASDAQ:NRXP traded up $2.39 during mid-day trading on Thursday, hitting $11.83. The stock had a trading volume of 331,048 shares, compared to its average volume of 1,865,897. The firm’s 50 day simple moving average is $12.11. NRx Pharmaceuticals has a 12-month low of $6.43 and a 12-month high of $76.99. The company has a debt-to-equity ratio of 2.34, a quick ratio of 0.52 and a current ratio of 0.52.

NRx Pharmaceuticals (NASDAQ:NRXP) last posted its quarterly earnings results on Monday, August 16th. The company reported ($6.51) EPS for the quarter.

Institutional investors and hedge funds have recently modified their holdings of the stock. Royal Bank of Canada bought a new position in shares of NRx Pharmaceuticals during the 2nd quarter worth approximately $93,000. Yakira Capital Management Inc. acquired a new position in NRx Pharmaceuticals during the 2nd quarter worth about $139,000. Geode Capital Management LLC bought a new stake in NRx Pharmaceuticals during the 2nd quarter worth about $400,000. Ionic Capital Management LLC bought a new position in shares of NRx Pharmaceuticals in the second quarter worth about $415,000. Finally, Morgan Stanley acquired a new position in shares of NRx Pharmaceuticals during the second quarter worth approximately $463,000. Hedge funds and other institutional investors own 3.37% of the company’s stock.

About NRx Pharmaceuticals

NRX Pharmaceuticals, Inc is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE.

Featured Story: How does the Beige Book influence monetary policy?

Receive News & Ratings for NRx Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NRx Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.